These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2539201)

  • 21. Synergism of the toxicity of physostigmine and neostigmine by lithium or by a reserpine-like agent (Ro4-1284).
    Davis WM; Hatoum NS
    Toxicology; 1980; 17(1):1-7. PubMed ID: 6904065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chin rub CRs are elicited by flavors associated with apomorphine, scopolamine, methscopolamine, physostigmine and neostigmine.
    Smith RJ; Parker LA
    Pharmacol Biochem Behav; 1985 Oct; 23(4):583-9. PubMed ID: 4070336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential response to cholinergic stimulation in psychogenitically selected rat lines.
    Martin JR; Driscoll P; Gentsch C
    Psychopharmacology (Berl); 1984; 83(3):262-7. PubMed ID: 6433388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
    Magnani M; Pozzi O; Biagetti R; Banfi S; Dorigotti L
    Psychopharmacology (Berl); 1992; 106(2):175-8. PubMed ID: 1549645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task.
    Wesnes K; Warburton DM
    Neuropsychobiology; 1983; 9(2-3):154-7. PubMed ID: 6621852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinergic effects on spatial exploration and its memory.
    Kelly PH; Malanowski J
    Can J Physiol Pharmacol; 1993; 71(5-6):352-64. PubMed ID: 8402401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scopolamine and methylscopolamine differentially affect fixed-consecutive-number performance of male and female Wistar rats.
    van Haaren F; van Hest A; van Hattum T
    Pharmacol Biochem Behav; 1989 Jun; 33(2):361-5. PubMed ID: 2813474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central and peripheral cholinergic involvement in the habituation of investigatory head poking in rats.
    Green SE; Summerfield A
    J Comp Physiol Psychol; 1977 Dec; 91(6):1398-1407. PubMed ID: 599198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilocarpine, a non-hallucinogenic cholinergic agonist, elicits limb flicking in cats.
    Marini JL
    Pharmacol Biochem Behav; 1981 Dec; 15(6):865-9. PubMed ID: 7323111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure.
    Tetz LM; Rezk PE; Ratcliffe RH; Gordon RK; Steele KE; Nambiar MP
    Toxicol Ind Health; 2006 Jul; 22(6):255-66. PubMed ID: 16924957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholinergic rebound after chlorpromazine exacerbates lithium muscarinic-induced limbic seizures in rats: implications for psychiatric treatment.
    Bureau YR; Persinger MA
    Psychol Rep; 1991 Aug; 69(1):171-6. PubMed ID: 1660160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scopolamine differentially disrupts the behavior of male and female Wistar rats in a delayed nonmatching to position procedure.
    van Hest A; Stroet J; van Haaren F; Feenstra M
    Pharmacol Biochem Behav; 1990 Apr; 35(4):903-9. PubMed ID: 2345764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminative stimulus properties of physostigmine in rats.
    Tang AH; Franklin SR
    Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium modifies convulsions and brain phosphoinositide turnover induced by organophosphates.
    Savolainen KM; Muona O; Nelson SR; Samson FE; Pazdernik TL
    Pharmacol Toxicol; 1991 May; 68(5):346-54. PubMed ID: 1658765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-dependent effects of scopolamine on avoidance, locomotor activity, and rearing.
    Bauer RH
    Behav Brain Res; 1982 Jul; 5(3):261-79. PubMed ID: 7115569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation by inositol of cholinergic- and serotonergic-induced seizures in lithium-treated rats.
    Williams MB; Jope RS
    Brain Res; 1995 Jul; 685(1-2):169-78. PubMed ID: 7583243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of cholinergic activity and the aversive threshold in the rat.
    Houser VP; Van Hart DA
    Pharmacol Biochem Behav; 1974; 2(5):631-7. PubMed ID: 4431827
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the effects of scopolamine and methylscopolamine on the performance of a fixed-ratio discrimination in squirrel monkeys.
    Pakarinen ED; Moerschbaecher JM
    Pharmacol Biochem Behav; 1993 Apr; 44(4):815-9. PubMed ID: 8469694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental differences in the analgesia produced by the central cholinergic system.
    Hamm RJ; Knisely JS
    Dev Psychobiol; 1987 May; 20(3):345-54. PubMed ID: 3596060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of some cholinergic agonists on neocortical slow wave activity in rats with basal forebrain lesions.
    Vanderwolf CH; Raithby A; Snider M; Cristi C; Tanner C
    Brain Res Bull; 1993; 31(5):515-21. PubMed ID: 8495376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.